Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilma Hopman

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 21, 2020
Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced CancerAdi Kartolo, Ryan Holstead, Sidra Khalid, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2021
Evaluating the effectiveness of let's talk period's high school educational outreach program: A pilot studyLubnaa Hossenbaccus, Lisa Thibeault, Julie Grabell, et al.
Brachytherapy|October 8, 2023
Analysis of multicatheter interstitial brachytherapy: Accelerated partial breast irradiation in a retrospective cohort of early-stage breast cancer patientsSamantha Sigurdson, Stephane Thibodeau, Logan Montgomery, et al.
International Journal of Rheumatic Diseases|June 15, 2017
Detection of dermatological abnormalities in the rheumatology clinic using a standardized screening examNewton Wai Kwan Wong, Tanveer Ezad Towheed, Wilma Hopman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2021
Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced MelanomaAdi Kartolo, Jasna Deluce, Ryan Holstead, et al.
Cancer Treatment and Research Communications|January 6, 2023
A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemicLilian Hanna, Gordon Taylor Moffat, Wilma Hopman, et al.
Immunotherapy|November 11, 2021
Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitorsAdi Kartolo, Cynthia Yeung, Gordon T Moffat, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 14, 2005
Indicators of functional status for primary malignant brain tumour patientsMiguel Bussière, Wilma Hopman, Andrew Day, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 29, 2021
Validation of the pictorial blood loss assessment chart using modern sanitary productsMichaela Spence, Kalandra de Repentigny, Mackenzie Bowman, et al.
Immunotherapy|July 11, 2023
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemicGordon Taylor Moffat, Lilian Hanna, Wilma Hopman, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 21, 2020
Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced CancerAdi Kartolo, Ryan Holstead, Sidra Khalid, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2021
Evaluating the effectiveness of let's talk period's high school educational outreach program: A pilot studyLubnaa Hossenbaccus, Lisa Thibeault, Julie Grabell, et al.
Brachytherapy|October 8, 2023
Analysis of multicatheter interstitial brachytherapy: Accelerated partial breast irradiation in a retrospective cohort of early-stage breast cancer patientsSamantha Sigurdson, Stephane Thibodeau, Logan Montgomery, et al.
International Journal of Rheumatic Diseases|June 15, 2017
Detection of dermatological abnormalities in the rheumatology clinic using a standardized screening examNewton Wai Kwan Wong, Tanveer Ezad Towheed, Wilma Hopman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2021
Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced MelanomaAdi Kartolo, Jasna Deluce, Ryan Holstead, et al.
Cancer Treatment and Research Communications|January 6, 2023
A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemicLilian Hanna, Gordon Taylor Moffat, Wilma Hopman, et al.
Immunotherapy|November 11, 2021
Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitorsAdi Kartolo, Cynthia Yeung, Gordon T Moffat, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 14, 2005
Indicators of functional status for primary malignant brain tumour patientsMiguel Bussière, Wilma Hopman, Andrew Day, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 29, 2021
Validation of the pictorial blood loss assessment chart using modern sanitary productsMichaela Spence, Kalandra de Repentigny, Mackenzie Bowman, et al.
Immunotherapy|July 11, 2023
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemicGordon Taylor Moffat, Lilian Hanna, Wilma Hopman, et al.
Pageof 12